Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.21.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 9,680 $ 5,413
Receivables 103 884
Inventory 129 328
Prepaid expenses and other current assets 648 522
Discontinued operations - current assets 70 181
Total current assets 10,630 7,328
Property and equipment, net 524 618
Operating lease right-of-use asset 353 141
Total assets 11,507 8,087
Current liabilities:    
Accounts payable 439 1,253
Accrued clinical trials expenses 38 214
Other accrued liabilities 304 319
Operating lease liability, current 108 150
Current portion of long-term debt 0 327
Discontinued operations - current liabilities 1,627 1,960
Total current liabilities 2,516 4,223
Operating lease liability, noncurrent 244 0
Long-term debt 0 332
Total liabilities 2,760 4,555
Stockholders' equity:    
Common stock, at amounts paid-in 10 7
Additional paid-in capital 380,337 370,804
Accumulated deficit (371,600) (367,279)
Total stockholders' equity 8,747 3,532
Total liabilities and stockholders' equity $ 11,507 $ 8,087